Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by DryBoneson Jun 28, 2018 3:17pm
152 Views
Post# 28246879

a boob job

a boob joband not a very convincing one when a face lift was needed.  
I am of the opinion that the new consultants will likely work out.  They need to be part bureaucrat, part scientist.  Wendell could probably get a deal done but it will no longer be a particularly good one.

Take a look at T. ONC.  Their reverse onto Nazdaq is not being successful.  Think of what would have happened had PLI done the same.  

Management changes still needed. As a minimum.....

CFO must go.  
CFO must go.
CFO must go.
CFO must go.
Bullboard Posts